ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
EV to Sales: Discounted ValuationCompressed
Percentile Rank7
3Y CAGR-5.6%
5Y CAGR-25.9%
Year-over-Year Change
Enterprise value to sales ratio
3Y CAGR
-5.6%/yr
vs -13.1%/yr prior
5Y CAGR
-25.9%/yr
Recent acceleration
Acceleration
+7.5pp
Accelerating
Percentile
P7
Near historical low
vs 5Y Ago
0.2x
Contraction
Streak
1 yr
Consecutive growthCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.10 | +41.7% |
| 2024 | 2.90 | -57.9% |
| 2023 | 6.88 | +41.1% |
| 2022 | 4.87 | -35.6% |
| 2021 | 7.57 | -58.9% |
| 2020 | 18.41 | +2.1% |
| 2019 | 18.04 | +111.2% |
| 2018 | 8.54 | -70.5% |
| 2017 | 29.00 | -84.2% |
| 2016 | 183.35 | - |